8 Indications for, and use of, cytotoxic agents in SLE-Reference-Cited by-同舟云学术

8 Indications for, and use of, cytotoxic agents in SLE

Published:1998-08 Issue:3 Volume:12 Page:511-527
ISSN:0950-3579
Container-title:Baillière's Clinical Rheumatology
language:en
Short-container-title:Baillière's Clinical Rheumatology

Author:

Klippel John H.

Publisher

Elsevier BV

Subject

Rheumatology

Reference54 articles.

1. Methotrexate therapy in childhood systemic lupus erythematosus;Abud-Mendoza;Journal of Rheumatology,1993

2. The course and treatment of lupus nephritis;Appel;Annual Review of Medicine,1994

3. Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs;Austin;New England Journal of Medicine,1986

4. Lupus membranous nephropathy: controlled trial of prednisone, pulse cyclophosphamide, and cyclosporine;Austin;Journal of the American Society of Nephrology,1996

5. Effect of treatment on the evolution of renal abnormalities in lupus nephritis;Balow;New England Journal of Medicine,1984

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcome in patients with suspected inflammatory neuropsychiatric lupus treated with immunosuppression: an observational cohort study;Lupus Science & Medicine;2023-02

2. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis;Modern Rheumatology;2014-08-27

3. Belimumab in systemic lupus erythematosus: an update for clinicians;Therapeutic Advances in Chronic Disease;2011-10-23

4. Elimination of autoreactive B cells in humanized SCID mouse model of SLE;European Journal of Immunology;2011-09-28

5. Humanized SCID Mice Models of SLE;Current Pharmaceutical Design;2011-05-01